Clinical Trials Directory

Trials / Completed

CompletedNCT04373759

Cardiac Arrest Incidence and Outcome Among Patients With COVID-19 in French ICUs

Cardiac Arrest Incidence and Outcome Among Patient With COVID-19 Pneumonia in French ICUs

Status
Completed
Phase
Study type
Observational
Enrollment
186 (actual)
Sponsor
Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for the novel coronavirus disease 2019 (COVID-19) pandemic. Among COVID-19 complications, in-hospital cardiac arrest (IHCA) was reported with a very poor outcome in a retrospective single-center study (0,7% of 30 days survival with good neurological outcome among IHCA patients with a resuscitation attempt), related to its natural course and management. The incidence of unexpected in-ICU cardiac arrest (ICUCA) due to COVID-19 is still unknown. Additionally, outcome of COVID-19 patients admitted in ICU for an out-of-hospital cardiac arrest (OHCA) is also undescribed. The objective this study is : * to report the incidence of ICUCA among patients hospitalized in French ICU for COVID-19. * to report morbidity and mortality among COVID-19 patients admitted alive in ICU for an OHCA or an IHCA. The secondary objective is to assess outcome and identify risk factors of ICUCA occurrence among patients admitted for COVID-19.

Detailed description

Retrospective and prospective multicentric observational registry in French intensive care units (ICU) including all consecutive adult patients admitted in ICU with a documented SARS-CoV-2 disease : * For an out-of-hospital or an in-hospital cardiac arrest (OHCA and IHCA respectively) * Or presenting an unexpected in-ICU cardiac arrest (ICUCA) Patients characteristics, cardiac arrest history and patients outcome will be recorded according to Utstein recommendations. Patients presenting an expected cardiac arrest in ICU related to withdrawal of life sustaining therapies (WLST) will be excluded.

Conditions

Interventions

TypeNameDescription
OTHERCardiopulmonary resuscitationCardiopulmonary resuscitation
OTHERModified Rankin score0 - no symptoms at all 1. \- no significant disability despite symptoms; able to carry out all usual duties and activities 2. \- Slight disability; unable to carry out all previous activities, but able to look after own affairs without assistance 3. \- Moderate disability; requiring some help, but able to walk without assistance 4. \- Moderately severe disability; unable to walk and attend to bodily needs without assistance 5. \- Severe disability; bedridden, incontinent and requiring constant nursing care and attention 6. \- Dead

Timeline

Start date
2020-05-02
Primary completion
2020-09-30
Completion
2020-09-30
First posted
2020-05-04
Last updated
2022-10-13

Locations

36 sites across 2 countries: France, Martinique

Source: ClinicalTrials.gov record NCT04373759. Inclusion in this directory is not an endorsement.